hsa-miR-625-3p

ncRNA information

ncRNA name

hsa-miR-625-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

MAP2K6-p38

Cancer information

Cancer name

Colorectal Adenocarcinoma

Cancer site

Colon, Rectum, and Anus

Treatment information

Treatment type

Chemotherapy

Drug

Oxaliplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Ectopic expression of miR-625-3p promotes Oxaliplatin resistance.

Tissue resource

primary colorectal cancer biopsies

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Departments of Odense University Hospital and Aarhus University Hospital

Country

Denmark

Continent

Europea